Related Experiment Video
Updated: Jan 16, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
Seraph® 100 Microbind® utilization in immunocompromised toddler with adenovirus viremia in conjunction with
Guyu Li1, Christian Hanna2, Laura M Dinnes3
1Division of Pediatric Infectious Diseases, Department of Pediatrics, Mayo Clinic, Rochester, MN, USA.
Abstract:
The Seraph® 100 Microbind® is an extracorporeal, sorbent hemoperfusion device intended to adsorb pathogens when integrated into extracorporeal circuits. We describe the use of Seraph 100 in an 18-month-old immunocompromised toddler with adenovirus viremia in conjunction with continuous renal replacement therapy and extracorporeal membrane oxygenation.
More Related Videos
10:24Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
09:06Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
Published on: December 12, 2025
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Respiratory Failure-IV
Kidney Transplant III: Nursing Management
Acute Kidney Injury I: Introduction